Healthcare provider profile · identity verified

Delwyn Sargeant, MD

Internal Medicine · PHILADELPHIA, PA · NPI 1285606913

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	876	205
Amlodipine Besylate	Amlodipine Besylate	606	166
Gabapentin	Gabapentin	341	100
Losartan Potassium	Losartan Potassium	326	79
Lisinopril	Lisinopril	303	74
Furosemide	Furosemide	263	67
Metoprolol Succinate	Metoprolol Succinate	257	67
Albuterol Sulfate Hfa	Albuterol Sulfate	250	77
Omeprazole	Omeprazole	232	56
Metformin Hcl	Metformin Hcl	229	62
Hydrochlorothiazide	Hydrochlorothiazide	224	60
Pantoprazole Sodium	Pantoprazole Sodium	191	50
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	189	50
Rosuvastatin Calcium	Rosuvastatin Calcium	184	55
Fluticasone Propionate	Fluticasone Propionate	183	61
Jardiance	Empagliflozin	176	38
Tamsulosin Hcl	Tamsulosin Hcl	145	41
Mirtazapine	Mirtazapine	129	32
Trazodone Hcl	Trazodone Hcl	128	27
Carvedilol	Carvedilol	122	29
Famotidine	Famotidine	121	33
Nifedipine Er	Nifedipine	120	21
Levothyroxine Sodium	Levothyroxine Sodium	115	23
Diclofenac Sodium	Diclofenac Sodium	113	39
Eliquis	Apixaban	111	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	108	27
Ozempic	Semaglutide	102	20
Triamcinolone Acetonide	Triamcinolone Acetonide	100	27
Duloxetine Hcl	Duloxetine Hcl	90	20
Allopurinol	Allopurinol	85	19
Potassium Chloride	Potassium Chloride	81	18
Sertraline Hcl	Sertraline Hcl	80	19
Montelukast Sodium	Montelukast Sodium	79	16
Alendronate Sodium	Alendronate Sodium	78	16
Metformin Hcl Er	Metformin Hcl	78	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	17
Spironolactone	Spironolactone	75	18
Lidocaine	Lidocaine	74	22
Baclofen	Baclofen	72	20
Oxybutynin Chloride Er	Oxybutynin Chloride	71	19
Clopidogrel	Clopidogrel Bisulfate	70	16
Tizanidine Hcl	Tizanidine Hcl	69	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	67	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	66	13
Ibuprofen	Ibuprofen	62	23
Pravastatin Sodium	Pravastatin Sodium	61	13
Donepezil Hcl	Donepezil Hcl	56	suppressed
Entresto	Sacubitril/Valsartan	56	13
Prednisone	Prednisone	52	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	13
Mounjaro	Tirzepatide	49	suppressed
Trulicity	Dulaglutide	49	suppressed
Aripiprazole	Aripiprazole	48	11
Naproxen	Naproxen	48	13
Escitalopram Oxalate	Escitalopram Oxalate	47	13
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	17
Lovastatin	Lovastatin	41	suppressed
Memantine Hcl	Memantine Hcl	41	suppressed
Calcitriol	Calcitriol	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	suppressed
Linzess	Linaclotide	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	38	12
Ketoconazole	Ketoconazole	38	14
Xarelto	Rivaroxaban	38	suppressed
Bumetanide	Bumetanide	37	suppressed
Atenolol	Atenolol	36	suppressed
Glipizide Er	Glipizide	36	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	36	suppressed
Glipizide	Glipizide	35	suppressed
Colchicine	Colchicine	33	suppressed
Repaglinide	Repaglinide	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Clobetasol Propionate	Clobetasol Propionate	31	suppressed
Novolog Flexpen	Insulin Aspart	31	suppressed
Irbesartan	Irbesartan	30	suppressed
Latanoprost	Latanoprost	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Myrbetriq	Mirabegron	29	suppressed
Simvastatin	Simvastatin	29	suppressed
Torsemide	Torsemide	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	16
Carvedilol Er	Carvedilol Phosphate	27	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Methimazole	Methimazole	24	suppressed
Nitroglycerin	Nitroglycerin	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Metolazone	Metolazone	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	12
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Desonide	Desonide	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Risperidone	Risperidone	20	suppressed
Cephalexin	Cephalexin	19	18
Clonidine	Clonidine	19	suppressed
Topiramate	Topiramate	19	suppressed
Valsartan	Valsartan	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Finasteride	Finasteride	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Azithromycin	Azithromycin	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Niacin Er	Niacin	13	suppressed
Budesonide Dr	Budesonide	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error